Europe PMCopen access
Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human disease
Senescence, Immunotherapy, NKG2D, Cancer Immunotherapy, Immune Surveillance, Chimeric Antigen Receptor (Car) T Cells
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 4654
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.